Sale!

KCTD3 Gene Neurodevelopmental Disorder Genetic Test

Original price was: $700.Current price is: $500.

-29%

The KCTD3 Gene Neurodevelopmental Disorder NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the KCTD3 gene associated with neurodevelopmental conditions. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect specific genetic variations that can cause developmental delays, intellectual disabilities, and neurological symptoms. Priced at $500 USD, this test provides crucial diagnostic information for individuals experiencing unexplained developmental challenges, helping families and healthcare providers understand the underlying genetic causes and develop targeted management strategies. The test requires a simple blood sample or extracted DNA and delivers results within 3-4 weeks, offering valuable insights for treatment planning and genetic counseling.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

KCTD3 Gene Neurodevelopmental Disorder NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurodevelopmental Conditions

The KCTD3 Gene Neurodevelopmental Disorder NGS Genetic DNA Test represents a significant advancement in neurological genetic diagnostics. This specialized test focuses on identifying mutations in the KCTD3 gene, which plays a crucial role in brain development and neurological function. Understanding the genetic basis of neurodevelopmental disorders is essential for accurate diagnosis, personalized treatment planning, and informed family planning decisions.

What Does the KCTD3 Gene Neurodevelopmental Disorder Test Measure?

This advanced genetic test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the KCTD3 gene for:

  • Point mutations and single nucleotide variations
  • Small insertions and deletions (indels)
  • Copy number variations affecting the KCTD3 gene
  • Structural variations that may impact gene function
  • Pathogenic variants associated with neurodevelopmental disorders

The KCTD3 gene encodes a protein involved in potassium channel tetramerization, which is critical for proper neuronal function and brain development. Mutations in this gene have been linked to various neurodevelopmental conditions characterized by intellectual disability, developmental delays, and neurological symptoms.

Who Should Consider This Genetic Test?

This test is particularly recommended for individuals presenting with:

  • Unexplained developmental delays in childhood
  • Intellectual disability of unknown origin
  • Neurological symptoms without clear diagnosis
  • Family history of neurodevelopmental disorders
  • Multiple family members with similar neurological conditions
  • Children with speech and language delays
  • Individuals with motor coordination difficulties
  • Patients with behavioral challenges and cognitive impairment

Key Benefits of KCTD3 Genetic Testing

Undergoing the KCTD3 Gene Neurodevelopmental Disorder NGS Genetic DNA Test offers numerous advantages:

  • Accurate Diagnosis: Provides definitive genetic confirmation of KCTD3-related disorders
  • Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
  • Family Planning: Offers valuable information for reproductive decision-making
  • Early Intervention: Facilitates timely interventions for better developmental outcomes
  • Genetic Counseling: Supports informed discussions about inheritance patterns and recurrence risks
  • Research Contribution: Contributes to ongoing scientific understanding of neurodevelopmental disorders

Understanding Your Test Results

Your KCTD3 genetic test results will be carefully interpreted by our team of genetic specialists and neurologists:

  • Positive Result: Indicates the presence of a pathogenic mutation in the KCTD3 gene, confirming the genetic basis of neurodevelopmental symptoms
  • Negative Result: Suggests that KCTD3 mutations are not responsible for the clinical presentation, guiding further diagnostic evaluation
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires additional investigation
  • Carrier Status: May reveal information about inheritance patterns and family risk assessment

All results are accompanied by comprehensive genetic counseling to ensure proper understanding and appropriate next steps.

Test Details and Pricing

Test Component Details
Test Name KCTD3 Gene Neurodevelopmental Disorder NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialty Neurology and Genetics

Pre-Test Requirements

Before undergoing the KCTD3 genetic test, we recommend:

  • Comprehensive clinical history documentation
  • Genetic counseling session with our specialists
  • Development of a detailed family pedigree chart
  • Discussion of testing implications and potential outcomes
  • Informed consent process

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of genetic testing centers ensures accessible, high-quality diagnostic services for patients nationwide.

Take the Next Step Toward Genetic Clarity

If you or your loved one is experiencing neurodevelopmental symptoms, the KCTD3 Gene Neurodevelopmental Disorder NGS Genetic DNA Test could provide the answers you need. Our team of genetic specialists and neurologists is ready to guide you through the testing process and help interpret your results.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Take control of your neurological health with advanced genetic testing from America’s leading genetics corporation.